Oncology

News

Celcuity gets FDA nod for first-in-class breast cancer drug

Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of breast cancer.

News

Digital check-ins improve cancer care and reduce inequality

A study has shown that, for people living with advanced cancer, a weekly remote check-in with the care team can have a significant impact on outcomes.

News

GSK to file Jemperli for rectal cancer after phase 3 readout

GSK's pivotal AZUR-1 trial of Jemperli monotherapy to delay or eliminate surgery in pre-operative rectal cancer has delivered a positive result.

News

Pay offer rejected as ICR researchers continue strike action

Researchers at the UK Institute of Cancer Research have held historic strikes over pay, claiming they are missing meals and struggling to cover bills.

News

NICE aims to cut funding for Amgen lung cancer drug Lumykras

Amgen's Lumykras will no longer be funded by the Cancer Drugs Fund for KRAS-mutated lung cancer, says NHS reimbursement authority NICE.

News

Roche looks to Astex in $515m breast cancer deal

Roche's Genentech unit has forged an alliance with Astex, worth up to $515m, to partner on a fragment-based drug discovery programme in breast cancer.

Celcuity gets FDA nod for first-in-class breast cancer drug

Digital check-ins improve cancer care and reduce inequality

GSK to file Jemperli for rectal cancer after phase 3 readout

Pay offer rejected as ICR researchers continue strike action

NICE aims to cut funding for Amgen lung cancer drug Lumykras

Roche looks to Astex in $515m breast cancer deal

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks